Why the study?
What is the degree of organ extraction of atrial natriuretic peptide (ANP) across different vascular beds in humans?
What is the degree of organ extraction of atrial natriuretic peptide (ANP) across different vascular beds in humans?
ANP undergoes significant but variable extraction across different vascular beds, highlighting the need to standardize sampling sites in clinical studies.
Answers are grounded in this paper and cite their sources.
ANP sampling sites warrant standardization in future studies; cross-sectional data leaves clinical assay implications open.
Arterial plasma immunoreactivity of endogenous human alpha-atrial natriuretic peptide (ANP) underwent mean 54%, 28% and 40% extraction during one passage through the circulation in the kidney (n = 12), liver-intestine (n = 14) and lower limb (n = 8), respectively, in supine fasting subjects with no detectable disease or subjects with cardiovascular or hepatic disorders of minor degree undergoing a haemodynamic investigation. No extraction was identified across the lungs as evaluated by the same concentration of ANP in pulmonary and femoral arteries (n = 7). The concentration of ANP in a superficial arm vein relative to the femoral artery varied considerably and extractions from 0% up to 58% were identified (mean 18%). The results suggest a high degree of, but only to some extent selective, extraction of ANP, which may account for its proposed short plasma half-life. Due to the different concentrations of ANP in various vascular beds, sampling site should be thoroughly specified.
No takes yet. Share an insight, caveat, or question.
Schütten et al. (1987) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: